Has Neal Atebara, MD received payments from drug or device companies?

Yes. Drug and device makers reported $922 in general payments to Neal Atebara, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Neal Atebara, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Neal Atebara, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Neal Atebara, MD

Ophthalmology · Honolulu, HINPI 1093828840

Payments from drug & device makers

$922in general payments, 2019–2025

Across 12 payments — averaging $76.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$258
Amgen$214
Genentech USA, Inc.$203
AbbVie$125
Regeneron Healthcare Solutions, Inc.$122

What the payments were for

Food & beverage$922100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	2	$258
Amgen(2 entities)	2	$214
Genentech USA, Inc.	6	$203
AbbVie	1	$125
Regeneron Healthcare Solutions, Inc.	1	$122

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$922 in reported general payments places this provider in the 30th percentile of 120 ophthalmology providers in Hawaii.

See all ophthalmology providers in Hawaii →

Medicare billing

Part B allowed, 2024

$716,094

Medicare patients

622

Services billed

11,813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
NevanacNepafenac	25	$8,422
Brimonidine Tartrate	13	$2,057
Tobramycin	251	$1,614
Prednisolone Acetate	30	$1,235
MoxifloxacinMoxifloxacin Hcl	22	$632
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	22	$228
Ketorolac Tromethamine	13	$169

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Honolulu

Carlton YuenHonolulu$440K
Neda NikpoorHonolulu$322K
Alan FaulknerHonolulu$207K
Michael BennettHonolulu$190K
Jeffrey PetersonHonolulu$85K
Rupa WongHonolulu$72K
Worldster LeeHonolulu$30K
Elysse TomHonolulu$20K
Jon PortisHonolulu$20K
Tyrie JenkinsHonolulu$19K

See the full list for Hawaii →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →